TMCnet News

Hyperthyroidism Drug Profiles and Clinical Trials Report - Global Trends and Analysis Review, H2 2017 - Research and Markets
[November 20, 2017]

Hyperthyroidism Drug Profiles and Clinical Trials Report - Global Trends and Analysis Review, H2 2017 - Research and Markets


The "Hyperthyroidism Drug Profiles and Clinical Trials - Global Trends and Analysis Review, H2 2017" report has been added to Research and Markets' offering.

Hyperthyroidism is a common form of thyroid disorder, which results from overactive thyroid functioning and is mostly observed in women, older population and patients with other thyroid issues. Extra secretion of thyroid hormones leads to speeding up of metabolism in the body. Accordingly, patients witness symptoms of anxiety, rapid heartbeat, shivering, excessive sweat excretion, weight loss and insomnia.

Auto-immune disorders including Graves' disease are a common cause of the condition. The disease leads the body to produce an anti-body termed thyroid-stimulating immunoglobulin (TSI (News - Alert)). The TSI results in the thyroid secreting additional thyroid hormones. In addition, lumps on thyroid gland and arrhythmia medications are also observed to cause hyperthyroidism.

Treatment options vary from patient to patient based on the condition including medication to reduce T3 and T4 hormone secretion, radioiodine and surgery.

Hyperthyroidism clinical trials report provides comprehensive analysis and trends in global Hyperthyroidism disease clinical trials. The research work analyzes the evolution of Hyperthyroidism clinical trial trends across countries and regions.

The report focuses on drugs and therapies being evaluated for Hyperthyroidism treatment in active clinical development phases including phase 1, phase 2, hase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, phases, trial status and sponsor types.



Major drugs under development in Hyperthyroidism are provided in the report along with their details of Mechanism of Action, Route of Administration, Target (News - Alert), therapy, molecule and class.

Scope of the Report:


  • Number of Hyperthyroidism clinical trials across regions - Asia and Oceania, Europe, Middle East Africa and Americas
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Hyperthyroidism
  • Both observational and interventional trials analyzed
  • Success rates of trials are analyzed
  • Trends in enrollment over the past ten years identified
  • Leading sponsors of Hyperthyroidism clinical trials worldwide are listed

Companies Mentioned

  • Aarhus University Hospital
  • Babol University of Medical Sciences
  • Bayer Inc
  • Boston Children's Hospital
  • Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
  • Chinese Academy of Medical Sciences, Fuwai Hospital
  • Clinical Nutrition Research Centre, Singapore
  • Department of Internal Medicine
  • Endocrine and Diabetes Center, Jiangsu Province Hospital on Integration of Chinese and Western Medicine
  • First Affiliated Hospital of Xi'an Jiaotong University
  • FONDAZIONE IRCCS CA' (News - Alert) GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO
  • General Hospital of Nanjing Military Region
  • Klinik für Neurologie UKSH Campus Lübeck
  • Mashhad University of Medical Sciences
  • Medical University of Vienna
  • Newcastle Upon Tyne Hospitals NHS Foundation Trust
  • Quanzhou First Hospital
  • Radboud Universitair Medisch Centrum
  • Ramathibodi Hospital
  • Rigshospitalet, Denmark
  • Royal Brisbane & Women's Hospital Foundation
  • Siriraj hospital
  • Sun Yat-sen University
  • The department of Endocrinology of Xinqiao Hospital, the Third Military Medical University, PLA
  • University of Pisa
  • Vice chancellor for Research and Technology of Kerman University of Medical Sciences, Physiology research
  • Vice Chancellor for Research of Tabriz University of Medical Sciences

For more information about this report visit https://www.researchandmarkets.com/research/wj9tlw/hyperthyroidism


[ Back To TMCnet.com's Homepage ]